Implantable Systems Performance Registry (ISPR)

This study is currently recruiting participants.
Verified November 2013 by MedtronicNeuro
Sponsor:
Information provided by (Responsible Party):
MedtronicNeuro
ClinicalTrials.gov Identifier:
NCT00959296
First received: August 13, 2009
Last updated: November 14, 2013
Last verified: November 2013

August 13, 2009
November 14, 2013
August 2003
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00959296 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Implantable Systems Performance Registry
Implantable Systems Performance Registry

The Implantable Systems Performance Registry (ISPR) was developed to evaluate the long-term reliability and performance of market-released Medtronic Neuromodulation infusion and stimulation products.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Primary Care Clinic

  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Drug Infusion (Implantable Pumps)
  • Sacral Nerve Stimulation
Device: Various
Patients implanted and consented at a study center with a market-released Medtronic implantable drug pump, spinal cord stimulator, deep brain stimulator, or sacral nerve stimulator.
Patients with a device implant
Patients implanted and consented at a study center with a market-released Medtronic implantable drug pump, spinal cord stimulator, deep brain stimulator, or sacral nerve stimulator.
Intervention: Device: Various
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
10000
Not Provided
Not Provided

Inclusion Criteria:

  • Scheduled for an implant or replacement with a market-released Medtronic implantable drug pump, spinal cord stimulator, deep brain stimulator, or sacral nerve stimulator

Exclusion Criteria:

  • Patient who is or will be inaccessible for follow-up at an ISPR study site
  • Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound the results of this study
Both
Not Provided
No
Contact: ISPR Team medtronicneurotrials@medtronic.com
United States,   Austria,   France,   Germany,   Italy,   Spain,   United Kingdom
 
NCT00959296
NSP0010-10000
No
MedtronicNeuro
MedtronicNeuro
Not Provided
Study Chair: ISPR Team Medtronic
MedtronicNeuro
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP